Log in to save to my catalogue

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mut...

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mut...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_63a2b8cb09d24e27bf69a399f673442e

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

About this item

Full title

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

Publisher

London: BioMed Central Ltd

Journal title

Arthritis research & therapy, 2021-09, Vol.23 (1), p.1-230, Article 230

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background Anti-modified protein antibodies (AMPA) targeting citrullinated, acetylated and/or carbamylated self-antigens are hallmarks of rheumatoid arthritis (RA). Although AMPA-IgG cross-reactivity to multiple post-translational modifications (PTMs) is evident, it is unknown whether the first responding B cells, expressing IgM, display similar ch...

Alternative Titles

Full title

Cross-reactivity of IgM anti-modified protein antibodies in rheumatoid arthritis despite limited mutational load

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_63a2b8cb09d24e27bf69a399f673442e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_63a2b8cb09d24e27bf69a399f673442e

Other Identifiers

ISSN

1478-6362,1478-6354

E-ISSN

1478-6362

DOI

10.1186/s13075-021-02609-5

How to access this item